Argine could influence brain tumour growth

Argine could influence brain tumour growth

Posted 15 October, 2021 at 12:21

Author Jessica McClory on behalf of In Sues Name


Arginine depletion clinical trial: plus expansion of research into paediatric and teenager / young adult tumours


The research team led by Dr. Nelofer Syed has a strong track record in studying the nutrients used in brain tumour metabolism, and were the first to identify the fact that arginine (an amino acid, one of the building blocks of protein) is used differently by brain cancer cells compared to healthy brain cells, and that by manipulating the relevant metabolic pathways, arginine levels could be used to influence tumour growth.

They have now completed an early stage clinical trial led by Dr Peter Szlosarek at Barts and the London School of Medicine, and are preparing to take these promising results into a larger trial alongside re-irradiation for adult patients with recurrent glioblastoma multiforme (GBM).

With your support we could not only move this trial forward more quickly so that patients can start to be offered this new treatment as soon as possible, but could start to work towards clinical trials for children, teenagers and young adults. In collaboration with Prof Tracy Warr at the University of Wolverhampton, Dr Syed and her team are already exploring the effectiveness of arginine deprivation in the laboratory using cells from paediatric ependymoma (a slow growing form of childhood brain tumour) and GBMs found in patients who are 18 to 20 years old. 

A huge challenge in brain tumour research is that there are many subtypes of tumour within each category, so a brain tumour in a younger patient shows distinct differences from a tumour found in an adult, even if they are classified within the same general name or arise from similar cells. Their tumours are therefore likely to respond differently to treatment, and as we move forward into an exciting era of personalised medicine, it is crucial that no patient group is left behind. 

Read more about the research team and study: Imperial College London Brain Tumour Research Centre of Excellence

More from In Sues Name

A new potential way to treat brain tumours is on the horizon...
Press Release

A new potential way to treat brain tumours is on the horizon...

26 November 2021
Vote for us to win a £1,000 donation this Christmas!
Press Release

Vote for us to win a £1,000 donation this Christmas!

24 November 2021
In Sue’s Name’s £1 million commitment to help find a cure for GBM
Press Release

In Sue’s Name’s £1 million commitment to help find a cure for GBM

22 November 2021
In Sue’s Name’s £1 million commitment to help find a cure for GBM
Press Release

In Sue’s Name’s £1 million commitment to help find a cure for GBM

18 November 2021
Card image cap
user

In Sues Name

Charity

Profile Feed
In Sue’s Name was founded in 2014 by David Taylor in memory of his beloved daughter Sue Blasotta, who died in 2011 of brain tumours. Sue was devoted to her husband Joe and their children Sasha and Daniel. She adored her career, first in recruitment with Reed Employment and then caring for ch...

32

Press Releases